Published in Pol Merkur Lekarski on February 01, 2002
Immunogenecity of hepatitis A vaccine in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis (2010) 1.49
[Diagnostic role of upper gastrointestinal endoscopy in pediatric inflammatory bowel diseases]. Pol Merkur Lekarski (2008) 0.86
Treatment of Helicobacter pylori infection in the aspect of increasing antibiotic resistance. Adv Clin Exp Med (2013) 0.85
[Blue rubber bleb naevus syndrome]. Pol Merkur Lekarski (2012) 0.85
Penetration of a selected antibiotic and antiseptic into a biofilm formed on orthopedic steel implants. Ortop Traumatol Rehabil (2007) 0.83
[Intestinal complications and extraintestinal manifestations in children with inflammatory bowel disease]. Pol Merkur Lekarski (2006) 0.80
[Predisposing factors and results of pharmalogical treatment using ursodeoxycholic acid of gallbladder stones in children]. Pol Merkur Lekarski (2006) 0.79
Helicobacter pylori antigens in stool specimens of gastritis children before and after treatment. J Pediatr Gastroenterol Nutr (2003) 0.79
[Selected features determine pathogenicity of Staphylococcus haemolyticus]. Med Dosw Mikrobiol (2003) 0.79
The strongest resistance of Staphylococcus aureus to erythromycin is caused by decreasing uptake of the antibiotic into the cells. Cell Mol Biol Lett (2012) 0.78
Invasive properties, adhesion patterns and phylogroup profiles among Escherichia coli strains isolated from children with inflammatory bowel disease. Adv Clin Exp Med (2013) 0.78
Metalloproteinase-3 and -9 as novel markers in the evaluation of ulcerative colitis activity in children. Adv Clin Exp Med (2014) 0.77
[Ascites and extreme lipid abnormalities as initial symptoms of cystic fibrosis in a 5-years-old girl--case report]. Pol Merkur Lekarski (2009) 0.77
[Assessment of fecal calprotectin concentration as inflammatory marker in inflammatory bowel diseases in children--preliminary report]. Pol Merkur Lekarski (2010) 0.77
Monotherapy with infliximab versus combination therapy in the maintenance of clinical remission in children with moderate to severe Crohn disease. J Pediatr Gastroenterol Nutr (2015) 0.77
Somatic development disorders of children with non specific inflammatory bowel diseases. Dev Period Med (2014) 0.76
[H. pylori infections in children: clinical, diagnostic and treatment implications]. Pol Merkur Lekarski (2013) 0.76
The triple "a" syndrome confirmed by molecular analysis: a case report of 7-year-old boy. J Pediatr Gastroenterol Nutr (2005) 0.76
The antimicrobial susceptibility of Helicobacter pylori strains isolated from children and adults with primary infection in the Lower Silesia Region, Poland. Pol J Microbiol (2014) 0.75
[Siderophores and hemolysins in iron aquisition by Acinetobacter genus]. Med Dosw Mikrobiol (2003) 0.75
[Complications of endoscopy in children]. Pol Merkur Lekarski (2008) 0.75
[Determination of milk and diary products consumption and their connection with lactose malabsorption or lactose intolerance in selected disorders of the alimentary tract in children]. Pol Merkur Lekarski (2009) 0.75
[Late diagnosed celiac disease in a mother and thre doughters]. Pol Merkur Lekarski (2014) 0.75
Gastroesophageal reflux disease accompanying urticaria pigmentosa. Acta Dermatovenerol Croat (2011) 0.75
[The effect of culture conditions on expression of surface proteins from coagulase-negative staphylococci isolated from clinical material of newborns hospitalized in an intensive care unit]. Med Dosw Mikrobiol (2002) 0.75
[Prevalence of H. pylori infection in the Polish child population]. Pol Merkur Lekarski (2005) 0.75
[Eosinophilic esophagitis leads to dysphagia in a 18-year-old boy--case report]. Pol Merkur Lekarski (2007) 0.75
[The frequency of anemia in children with newly diagnosed Crohn's disease in children]. Pol Merkur Lekarski (2013) 0.75
[Biological treatment of inflammatory bowel diseases in children in the years 2004-2013 in Poland]. Pol Merkur Lekarski (2014) 0.75
[Determination of lactose intolerance frequency in children with food allergy]. Pol Merkur Lekarski (2008) 0.75
[Risk of coagulase-negative staphylococci infections in catheterized patients due to adhesion and slime production]. Pol Merkur Lekarski (2004) 0.75
[Carbonyl groups content in serum proteins as an indicator of disease activity in children with inflammatory bowel diseases and its dependence on the other markers of inflammatory process]. Pol Merkur Lekarski (2008) 0.75
[Lactose intolerance: pathophysiology, clinical symptoms, diagnosis and treatment]. Pol Merkur Lekarski (2009) 0.75
[Williams syndrome in 2-year-old boy]. Wiad Lek (2007) 0.75
[Frequency of anemia in ulcerative colitis in children]. Pol Merkur Lekarski (2012) 0.75
[Severe toxic diarrhoea in cyclosporin treated 11-years old girl with nephrotic syndrome]. Pol Merkur Lekarski (2007) 0.75
[Diagnostic validity of anti-tissue transglutaminase and anti-endomysium antibodies in children with celiac disease]. Pol Merkur Lekarski (2006) 0.75
[A case of a 16.5-year-old boy with myelosis funicularis caused by secondary vitamin B12 deficiency associated with dietary deficiencies - case report]. Pol Merkur Lekarski (2013) 0.75
[Galbladder contractility in children with functional dyspepsia]. Pol Merkur Lekarski (2013) 0.75
[Antibodies to Klebsiella O-antigens in patients with seronegative spondyloarthropaties]. Pol Arch Med Wewn (2006) 0.75
[Role of the matrix metalloproteinases activity in inflammatory bowel disease]. Pol Merkur Lekarski (2010) 0.75
[Assessment of bone mineral density in children with celiac disease]. Pol Merkur Lekarski (2008) 0.75
[Nodular lymphoid hyperplasia--underestimated problem of gastrointestinal tract pathology in children]. Pol Merkur Lekarski (2008) 0.75
[Anemia in selected diseases of the gastrointestinal tract in children]. Pol Merkur Lekarski (2013) 0.75
[Blue rubber bleb naevus syndrome--a rare cause of bleeding from the gastrointestinal tract--case report]. Pol Merkur Lekarski (2012) 0.75
[Atypical manifestation of toxocariasis in 17-year-old boy--a case report]. Pol Merkur Lekarski (2008) 0.75
[Assessment of selected tests in diagnostics of Helicobacter pylori infections]. Pol Merkur Lekarski (2005) 0.75
[Adhesive properties and antibiotic resistance of Klebsiella strains isolated from gastrointestinal tracts of children hospitalised in Wroclaw nad Opole]. Med Dosw Mikrobiol (2003) 0.75
[Adhesion dependence of coagulase-negative staphylococci to biomaterials and PIA polysaccharide synthesis on icaADBC operon presence]. Med Dosw Mikrobiol (2004) 0.75
[Refractory celiac disease]. Pol Merkur Lekarski (2013) 0.75
[Frequency of Helicobacter pylori infection in patients with different clinical symptoms]. Przegl Lek (2005) 0.75
Major structural proteins of type 1 and type 3 Klebsiella fimbriae are effective protein carriers and immunogens in conjugates as revealed from their immunochemical characterization. FEMS Immunol Med Microbiol (2005) 0.75